2,3-Dihydroxypropyl oleate

2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.

Cross Reference

Introduction

To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate

PubChem Associated disorders and diseases

What pathways are associated with 2,3-Dihydroxypropyl oleate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2,3-Dihydroxypropyl oleate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2,3-Dihydroxypropyl oleate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What genes are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2,3-Dihydroxypropyl oleate

Download all related citations
Per page 10 20 50 100 | Total 520
Authors Title Published Journal PubMed Link
Esposito E et al. Monoolein liquid crystalline phases for topical delivery of crocetin. 2018 Colloids Surf B Biointerfaces pmid:30015140
Liu J et al. Quantitative ratiometric phosphorescence hypoxia-sensing nanoprobes based on quantum dots/Ir(III) glycerol monoolein cubic-phase nanoparticles. 2017 Biosens Bioelectron pmid:28667838
Esposito E et al. Lipid nanoparticles for administration of poorly water soluble neuroactive drugs. 2017 Biomed Microdevices pmid:28526975
Ng WY et al. Monoolein-alginate beads as a platform to promote adenosine cutaneous localization and wound healing. 2017 Int. J. Biol. Macromol. pmid:28456646
Souza C et al. Effect of Liquid Crystalline Systems Containing Antimicrobial Compounds on Infectious Skin Bacteria. 2017 AAPS PharmSciTech pmid:28028794
Nielsen LH et al. Microcontainers as an oral delivery system for spray dried cubosomes containing ovalbumin. 2017 Eur J Pharm Biopharm pmid:27993733
Takahashi H and Jojiki K Water isotope effect on the lipidic cubic phase: Heavy water-Induced interfacial area reduction of monoolein-Water system. 2017 Chem. Phys. Lipids pmid:28888939
Ahirrao M and Shrotriya S In vitro and in vivo evaluation of cubosomal in situ nasal gel containing resveratrol for brain targeting. 2017 Drug Dev Ind Pharm pmid:28574732
Cortesi R et al. Monoolein aqueous dispersions as a delivery system for quercetin. 2017 Biomed Microdevices pmid:28484916
Esposito E et al. Nanostructured lipid dispersions for topical administration of crocin, a potent antioxidant from saffron (Crocus sativus L.). 2017 Mater Sci Eng C Mater Biol Appl pmid:27987758
Jang Y et al. Absorption mechanism of DHP107, an oral paclitaxel formulation that forms a hydrated lipidic sponge phase. 2017 Acta Pharmacol. Sin. pmid:27867185
Mishraki-Berkowitz T et al. Structural properties and release of insulin-loaded reverse hexagonal (HII) liquid crystalline mesophase. 2017 J Colloid Interface Sci pmid:27701016
Ali MA et al. Enhancing the Solubility and Oral Bioavailability of Poorly Water-Soluble Drugs Using Monoolein Cubosomes. 2017 Chem. Pharm. Bull. pmid:28049915
Muheem A et al. A Combinatorial Statistical Design Approach to Optimize the Nanostructured Cubosomal Carrier System for Oral Delivery of Ubidecarenone for Management of Doxorubicin-Induced Cardiotoxicity: In Vitro-In Vivo Investigations. 2017 J Pharm Sci pmid:28552692
Levin A et al. Lipid Phase Control and Secondary Structure of Viral Fusion Peptides Anchored in Monoolein Membranes. 2017 J Phys Chem B pmid:28829131
Gabr MM et al. Hexagonal Liquid Crystalline Nanodispersions Proven Superiority for Enhanced Oral Delivery of Rosuvastatin: In Vitro Characterization and In Vivo Pharmacokinetic Study. 2017 J Pharm Sci pmid:28479357
Deshpande S and Singh N Influence of Cubosome Surface Architecture on Its Cellular Uptake Mechanism. 2017 Langmuir pmid:28325047
Zhai J et al. Self-assembled Lyotropic Liquid Crystalline Phase Behavior of Monoolein-Capric Acid-Phospholipid Nanoparticulate Systems. 2017 Langmuir pmid:28191966
Biffi S et al. Cubosomes for in vivo fluorescence lifetime imaging. 2017 Nanotechnology pmid:28032617
Szlezak M et al. Monoolein Cubic Phase Gels and Cubosomes Doped with Magnetic Nanoparticles-Hybrid Materials for Controlled Drug Release. 2017 ACS Appl Mater Interfaces pmid:28029248